Other startups, like MassRoots,
look to provide a social space for cannabis users to connect, but Hellomd is looking specifically to offer access to info.
Most of Hellomd's revenue comes from their telehealth prescriptions,
which cost $49 per consult, but they're now taking in some money from brands connecting with users on the platform.
And Hadfield and Lister say that's driving a lot of news sign-ups, and a lot of new organic traffic from search,
which accounts for 65 percent of Hellomd's current traffic overall.
And while the core business began as a way to use telemedicine to connect
doctors with patients for medicinal marijuana prescriptions, Hellomd founder Pamela Hadfield tells me it's since become something more.
Hellomd is currently bootstrapped, but
Hadfield and Lister say they're looking for funding, though they also say they're currently cash-flow positive and will be in a place this calendar year where they're comfortable continuing to self-fund if the investment picture doesn't line up.